From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

July 9th – an evening with Nigel Wray, Tom Winnifrith, Optibiotix and more – grab a free seat today

By Tom Winnifrith | Sunday 10 June 2018


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Maybe you cannot wait for the UK Investor Show 2019 on March 30? Well if that is the case here is a bonus preview event for you all, the first UK Investor City evening with Nigel Wray. Nigel will be joined in conversation by Tom Winnifrith  - that is me - and there will be four truly disruptive companies presenting including Cambridge Cognition and Optibiotix.

The event is taking place in Central London and includes drinks and canapes from 6 PM on Monday 9th July. There will be a chance to chat to all the speakers in an informal session, with more drinks and canapes, after the event.

Places are limited and will be allocated on a strictly first come first served basis. To book your free seat click HERE

Nigel Wray, the man known as Britain’s Buffett, will be discussing with me the threats and opportunities that he sees as a long term value investor and also what specifically he is investing in right now, notwithstanding the fact that the stockmarket is still at near all-time highs.

Each of the companies attending, including £34 million capitalised Cambridge Cognition (COG) where Wray has a large stake and has been adding to his holding, and £59 million Optibiotix (OPTI), my largest single holding where I too have been buying, can be described as “disruptors” in their own fields. To discover what the excitement is about book your seats now.

Places are limited and will be allocated on a strictly first come first served basis. To book your free seat click HERE

I look forward to seeing you in Central London on Monday July 9th

 

This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 07:55:37